Imagine Pharma Launches the Imagine Pharma Foundation to Advance Metabolic Research with a Focus on Veterans
PITTSBURGH, Jan. 23, 2024 /PRNewswire/ -- Imagine Pharma, a biotech company focused on furthering the commercialization opportunities related to its novel IMG-1 polypeptide across three distinct platforms: Oral Delivery, Therapeutics, and Regenerative Medicine, announced today the formation of The Imagine Pharma Foundation, a private not for profit charitable organization dedicated to advancing metabolic research to significantly impact the lives of those affected by diabetes, with a particular emphasis on serving veterans.
- The Imagine Pharma Foundation will collaborate with leading research institutions, pharmaceutical companies, healthcare providers, and other non-profit organizations, with a focus on four key areas: advancement of metabolic and diabetes research, increasing access to cutting-edge treatments for veterans and communities in need, supporting other non-profits focused on metabolic research and care and implementing education and awareness programs on diabetes prevention.
- Diabetes is a major global health concern, affecting nearly 25 percent of the Department of Veterans Affairs (VA) patient population.
- The disease is also the leading cause of blindness, end-stage renal disease, and amputation for VA patients.
- "Through cutting-edge research, collaboration and education, we aim to play a leading role in advancing research and treatment for diabetes and other metabolic diseases to help improve outcomes for those with this disease."